Insider Shareholders with Direct Ownership of Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a comprehensive overview of the insiders with direct ownership of Catalyst Pharmaceuticals, Inc. (CPRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CATALYST PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Patrick J Mcenany
Director |
1,885,166 | 2,179,693 | 4,478,169 $98.3 Million | 36 |
Aug 22, 2024
Reduced 0.11%
|
|
Charles B O'Keeffe
Director |
308,318 | 0 | 685,724 $15.1 Million | 12 |
Feb 15, 2024
Added 0.58%
|
|
Steve Miller
Chief Op. & Scientific Officer |
686,333 | 668,896 | 675,124 $14.8 Million | 19 |
Aug 20, 2024
Reduced 6.9%
|
|
Donald A Denkhaus
Director |
253,333 | 40,000 | 438,333 $9.63 Million | 13 |
Feb 15, 2024
Added 0.9%
|
|
David S Tierney
Director |
253,333 | 210,000 | 348,874 $7.66 Million | 22 |
Aug 21, 2024
Reduced 4.12%
|
|
Richard J Daly
President and CEO |
253,333 | 18,509 | 234,824 $5.16 Million | 13 |
Jun 04, 2024
Reduced 6.87%
|
|
Philip H Coelho
Director |
148,000 | 158,540 | 204,887 $4.5 Million | 17 |
May 04, 2023
Added 19.62%
|
|
Brian Elsbernd
Chief Compliance/Legal Officer |
224,999 | 100,566 | 124,433 $2.73 Million | 15 |
Mar 27, 2024
Reduced 16.73%
|
|
Alicia Grande
VP, Treasurer and CFO |
633,832 | 974,365 | 55,813 $1.23 Million | 34 |
Dec 27, 2023
Reduced 5.76%
|
|
Gary Ingenito
Chief Med. & Reg. Officer |
596,000 | 544,609 | 51,391 $1.13 Million | 24 |
Aug 09, 2024
Reduced 66.05%
|
|
Preethi Sundaram
Chief Strategy Officer |
114,999 | 89,458 | 25,541 $560,880 | 10 |
Feb 15, 2024
Reduced 19.09%
|
|
Jeffrey Del Carmen
Chief Commercial Officer |
283,156 | 242,507 | 12,369 $271,623 | 20 |
Aug 09, 2024
Reduced 70.81%
|
|
Molly Harper
Director |
19,333 | 19,333 | 0 $0 | 6 |
Jun 03, 2024
Reduced 100.0%
|